Adverse Drug Reaction News Bulletins
ADR News Bulletin 2025 May (Volume 27 Number 1)
Audiences
Healthcare professional
Industry member
Product type
Therapeutic Products
5 May 2025
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
Bulletin Highlights:
mRNA COVID-19 vaccine safety update: Insights from nationwide surveillance
Analysis of adverse event reports for year 2024
AE Case in Focus: Test Yourself - What could have caused the renal impairment in this patient?
Click on the link below to download the issue in pdf:
ADR_News_May2025_Vol27_No1 [PDF, 1505 KB]
News drugs approved in 2024:
Healthcare professionals are encouraged to report all serious and non-serious suspected adverse drug reactions (ADRs) with the use of new drugs. Your active participation in the ADR monitoring programme will provide valuable support to the post-marketing surveillance on drug safety.
Click on the link below to download the issue in pdf: